Answers are grounded in this paper and cite their sources.
This study showed that pioglitazone could be a tolerable and effective adjunctive therapy for improving depressive symptoms in bipolar disorder without type 2 diabetes or metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Zeinoddini et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: